FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385607577> ?p ?o ?g. }

• W4385607577 endingPage "1699" @default.
• W4385607577 startingPage "1699" @default.
• W4385607577 abstract "New Jersey was among the first states impacted by the COVID-19 pandemic, with one of the highest overall death rates in the nation. Nevertheless, relatively few reports have been published focusing specifically on New Jersey. Here we report on molecular, clinical, and epidemiologic observations, from the largest healthcare network in the state, in a cohort of vaccinated and unvaccinated individuals with laboratory-confirmed SARS-CoV-2 infection. We conducted molecular surveillance of SARS-CoV-2-positive nasopharyngeal swabs collected in nine hospitals from December 2020 through June 2022, using both whole genome sequencing (WGS) and a real-time RT-PCR screening assay targeting spike protein mutations found in variants of concern (VOCs) within our region. De-identified clinical data were obtained retrospectively, including demographics, COVID-19 vaccination status, ICU admission, ventilator support, mortality, and medical history. Statistical analyses were performed to identify associations between SARS-CoV-2 variants, vaccination status, clinical outcomes, and medical risk factors. A total of 5007 SARS-CoV-2-positive nasopharyngeal swabs were successfully screened and/or sequenced. Variant screening identified three predominant VOCs, including Alpha (n = 714), Delta (n = 1877), and Omicron (n = 1802). Omicron isolates were further sub-typed as BA.1 (n = 899), BA.2 (n = 853), or BA.4/BA.5 (n = 50); the remaining 614 isolates were classified as “Other”. Approximately 31.5% (1577/5007) of the samples were associated with vaccine breakthrough infections, which increased in frequency following the emergence of Delta and Omicron. Severe clinical outcomes included ICU admission (336/5007 = 6.7%), ventilator support (236/5007 = 4.7%), and mortality (430/5007 = 8.6%), with increasing age being the most significant contributor to each (p < 0.001). Unvaccinated individuals accounted for 79.7% (268/336) of ICU admissions, 78.3% (185/236) of ventilator cases, and 74.4% (320/430) of deaths. Highly significant (p < 0.001) increases in mortality were observed in individuals with cardiovascular disease, hypertension, cancer, diabetes, and hyperlipidemia, but not with obesity, thyroid disease, or respiratory disease. Significant differences (p < 0.001) in clinical outcomes were also noted between SARS-CoV-2 variants, including Delta, Omicron BA.1, and Omicron BA.2. Vaccination was associated with significantly improved clinical outcomes in our study, despite an increase in breakthrough infections associated with waning immunity, greater antigenic variability, or both. Underlying comorbidities contributed significantly to mortality in both vaccinated and unvaccinated individuals, with increasing risk based on the total number of comorbidities. Real-time RT-PCR-based screening facilitated timely identification of predominant variants using a minimal number of spike protein mutations, with faster turnaround time and reduced cost compared to WGS. Continued evolution of SARS-CoV-2 variants will likely require ongoing surveillance for new VOCs, with real-time assessment of clinical impact." @default.
• W4385607577 created "2023-08-06" @default.
• W4385607577 creator A5000349753 @default.
• W4385607577 creator A5000844274 @default.
• W4385607577 creator A5001787591 @default.
• W4385607577 creator A5011118388 @default.
• W4385607577 creator A5017289248 @default.
• W4385607577 creator A5018164475 @default.
• W4385607577 creator A5033311674 @default.
• W4385607577 creator A5038698652 @default.
• W4385607577 creator A5043837287 @default.
• W4385607577 creator A5044485195 @default.
• W4385607577 creator A5049843813 @default.
• W4385607577 creator A5052097511 @default.
• W4385607577 creator A5052234232 @default.
• W4385607577 creator A5054381823 @default.
• W4385607577 creator A5054782438 @default.
• W4385607577 creator A5060744391 @default.
• W4385607577 creator A5060779744 @default.
• W4385607577 creator A5064402497 @default.
• W4385607577 creator A5068655226 @default.
• W4385607577 creator A5091116725 @default.
• W4385607577 date "2023-08-05" @default.
• W4385607577 modified "2023-10-04" @default.
• W4385607577 title "Molecular and Clinical Epidemiology of SARS-CoV-2 Infection among Vaccinated and Unvaccinated Individuals in a Large Healthcare Organization from New Jersey" @default.
• W4385607577 cites W2039010316 @default.
• W4385607577 cites W2605343262 @default.
• W4385607577 cites W2952045272 @default.
• W4385607577 cites W3024517019 @default.
• W4385607577 cites W3033975073 @default.
• W4385607577 cites W3042021285 @default.
• W4385607577 cites W3046090203 @default.
• W4385607577 cites W3082920121 @default.
• W4385607577 cites W3087654809 @default.
• W4385607577 cites W3090717270 @default.
• W4385607577 cites W3099211712 @default.
• W4385607577 cites W3110738325 @default.
• W4385607577 cites W3111255098 @default.
• W4385607577 cites W3116955053 @default.
• W4385607577 cites W3117300734 @default.
• W4385607577 cites W3121461192 @default.
• W4385607577 cites W3126773711 @default.
• W4385607577 cites W3130332766 @default.
• W4385607577 cites W3133066666 @default.
• W4385607577 cites W3133532742 @default.
• W4385607577 cites W3145846289 @default.
• W4385607577 cites W3157429391 @default.
• W4385607577 cites W3160887443 @default.
• W4385607577 cites W3165679908 @default.
• W4385607577 cites W3173193467 @default.
• W4385607577 cites W3173609584 @default.
• W4385607577 cites W3177353388 @default.
• W4385607577 cites W3180301457 @default.
• W4385607577 cites W3180802407 @default.
• W4385607577 cites W3185521398 @default.
• W4385607577 cites W3186255276 @default.
• W4385607577 cites W3191934781 @default.
• W4385607577 cites W3195026952 @default.
• W4385607577 cites W3196140482 @default.
• W4385607577 cites W3196531163 @default.
• W4385607577 cites W3198874176 @default.
• W4385607577 cites W3199849883 @default.
• W4385607577 cites W3200630396 @default.
• W4385607577 cites W3203252807 @default.
• W4385607577 cites W3209130765 @default.
• W4385607577 cites W3209675485 @default.
• W4385607577 cites W4200112411 @default.
• W4385607577 cites W4200368137 @default.
• W4385607577 cites W4200429845 @default.
• W4385607577 cites W4200591468 @default.
• W4385607577 cites W4200614660 @default.
• W4385607577 cites W4205455327 @default.
• W4385607577 cites W4206069935 @default.
• W4385607577 cites W4206600586 @default.
• W4385607577 cites W4210611444 @default.
• W4385607577 cites W4211242522 @default.
• W4385607577 cites W4213425250 @default.
• W4385607577 cites W4220666151 @default.
• W4385607577 cites W4223505801 @default.
• W4385607577 cites W4225109414 @default.
• W4385607577 cites W4225265372 @default.
• W4385607577 cites W4225596202 @default.
• W4385607577 cites W4225835023 @default.
• W4385607577 cites W4226022810 @default.
• W4385607577 cites W4280587034 @default.
• W4385607577 cites W4281252777 @default.
• W4385607577 cites W4281291961 @default.
• W4385607577 cites W4282940436 @default.
• W4385607577 cites W4284701209 @default.
• W4385607577 cites W4284991343 @default.
• W4385607577 cites W4285498614 @default.
• W4385607577 cites W4285993171 @default.
• W4385607577 cites W4292731085 @default.
• W4385607577 cites W4293724184 @default.
• W4385607577 cites W4293999917 @default.
• W4385607577 cites W4294958301 @default.
• W4385607577 cites W4295899719 @default.
• W4385607577 cites W4297457941 @default.

• next